Kenilworth, New Jersey
Serbian gov't signs MoU with pharmaceuticals company MSD
BELGRADE - Serbian PM Ana Brnabic and the senior vice president of the pharmaceuticals firm Merck Sharp and Dohme (MSD), Cyril Schiever, signed on Wednesday a MoU that will be significant for Serbia's future BIO4 Campus research centre.
Brnabic thanked MSD for supporting "our efforts to make Serbia a leader in biotechnology, biomedicine, bioresearch and bioinformatics."